labetalol has been researched along with Embryopathies in 4 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fetal tachycardia was present as well." | 5.30 | Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. ( Bergmann, M; Bowman, ML; Smith, JF, 1998) |
| "The results of the treatment in hypertension with pregnancy by a alpha-beta blocker in 58 women show: the good tolerance of the drug and its lack of teratogenic effect, its quasi-constant efficiency (91%) in hypertension, its benefit repercussion on neonatal weight." | 5.27 | [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol]. ( Blazquez, G; Gérard, J; Giraud, P; Jeuffroy, A; Lardoux, H; Mounac, M, 1984) |
| "Hypertension in pregnancy has implications for both maternal and fetal welfare." | 2.37 | Hypertension in pregnancy. Pathophysiology and management. ( Lubbe, WF, 1984) |
| "Fetal tachycardia was present as well." | 1.30 | Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. ( Bergmann, M; Bowman, ML; Smith, JF, 1998) |
| "The results of the treatment in hypertension with pregnancy by a alpha-beta blocker in 58 women show: the good tolerance of the drug and its lack of teratogenic effect, its quasi-constant efficiency (91%) in hypertension, its benefit repercussion on neonatal weight." | 1.27 | [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol]. ( Blazquez, G; Gérard, J; Giraud, P; Jeuffroy, A; Lardoux, H; Mounac, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lubbe, WF | 1 |
| Gérard, J | 1 |
| Blazquez, G | 1 |
| Mounac, M | 1 |
| Giraud, P | 1 |
| Jeuffroy, A | 1 |
| Lardoux, H | 1 |
| de Vries, TW | 1 |
| van der Veer, E | 1 |
| Heijmans, HS | 1 |
| Bowman, ML | 1 |
| Bergmann, M | 1 |
| Smith, JF | 1 |
1 review available for labetalol and Embryopathies
| Article | Year |
|---|---|
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clon | 1984 |
3 other studies available for labetalol and Embryopathies
| Article | Year |
|---|---|
[Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
Topics: Adrenergic beta-Antagonists; Adult; Ethanolamines; Female; Fetal Diseases; Humans; Hypertension; Hyp | 1984 |
Warfarin embryopathy: patient, possibility, pathogenesis and prognosis.
Topics: Acenocoumarol; Bone and Bones; Developmental Disabilities; Drug Combinations; Female; Fetal Diseases | 1993 |
Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis.
Topics: Adolescent; Female; Fetal Diseases; Heart Rate, Fetal; Humans; Hypertension; Infant, Newborn; Infant | 1998 |